Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学BNT111 BNT113 mRNA Cancer Vaccine Trials

Matthew Bhatt

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Associate Professor of Medical Oncology

30
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Matthew Bhatt is a clinical investigator who has led or participated in key clinical trials evaluating mRNA cancer vaccines including BNT111 in melanoma and BNT113 in HPV-positive head and neck cancer. His research has defined the clinical pharmacology and immune response kinetics of mRNA cancer vaccines in combination with pembrolizumab. He characterized neoantigen-specific T cell responses induced by mRNA vaccines and their correlation with clinical outcomes. His work is advancing combination IO/mRNA vaccine strategies in the clinic.

Share:

🧪Research Fields 研究领域

BNT111 melanoma
BNT113 HPV cancer
mRNA cancer vaccine clinical trials
pembrolizumab combination
checkpoint plus vaccine

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Matthew Bhatt 的研究动态

Follow Matthew Bhatt's research updates

留下邮箱,当我们发布与 Matthew Bhatt(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment